Utilizing Multiomic Advanced Diagnostics to Identify Palbociclib Response Predictors and a Post-treatment Multiomic Signature for Patients with ER+/HER2- Metastatic Breast Cancer

Grant

Date/time Interval

  • April 19, 2017 - April 18, 2019
  • Total Award Amount

  • 205000.00
  • Direct Costs

  • 150735.00
  • Sponsor Award Id

  • Contributor

  • Erica Stringer-Reasor M.D.   Investigator  
  • Gabrielle Rocque M.D.   Investigator